Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
6,547,114
-
Share change
-
+859,223
-
Total reported value
-
$82,566,000
-
Price per share
-
$12.61
-
Number of holders
-
50
-
Value change
-
+$16,992,860
-
Number of buys
-
27
-
Number of sells
-
30
Institutional Holders of CONCERT PHARMACEUTICALS INC - COM (CNCE) as of Q3 2014
As of 30 Sep 2014,
CONCERT PHARMACEUTICALS INC - COM (CNCE) was held by
50 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,547,114 shares.
The largest 10 holders included
BVF INC/IL, FRANKLIN RESOURCES INC, Point72 Asset Management, L.P., BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, EAM Investors, LLC, WALL STREET ASSOCIATES, Ghost Tree Capital, LLC, SENZAR ASSET MANAGEMENT, LLC, and UBS AG.
This page lists
50
institutional shareholders reporting positions in this security
for the Q3 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.